Exponential Amplification-Induced Activation of CRISPR/Cas9 for Sensitive Detection of Exosomal miRNA.
Mengyang ZhouChao LiRong WeiHaoyu WangHaojie JiaChao YanLin HuangPublished in: Analytical chemistry (2024)
As an important component of highly heterogeneous exosomes, exosomal microRNAs (miRNAs) have great potential as noninvasive biomarkers for cancer diagnosis. Therefore, a sensitive and simple sensor is the key for its clinical application. Herein, we designed an exponential amplification reaction (EXPAR) to induce the reactivation of the CRISPR-associated protein 9/small guide RNA (Cas9/sgRNA) complex, thus achieving sensitive and visual exosomal miRNAs-21 (miR-21) fluorescence sensing. In this design, we inactivated the sgRNA by hybridizing sgRNA and blocker DNA. Then, we used a trigger DNA to hybridize with miR-21 and produced a lot of activated DNA by EXPAR. Those activated DNA further hybridized with blocker DNA and released the free sgRNA to form the activated Cas9/sgRNA complex. Based on the quick cleavage of activated Cas9/sgRNA complex, the reporter DNA labeled by SYBR Green I was released from the surface of the magnetic nanoparticles (MNPs) into the supernatant, and thus was used to sensitively quantify the miRNAs concentration with a limit of detection of 3 × 10 3 particles/mL. In addition, this fluorescence sensor has also been successfully employed to distinguish healthy people and cancer patients by naked-eye observation of the fluorescence, thus demonstrating its great potential for accurate and point-of-care cancer diagnosis.
Keyphrases
- crispr cas
- single molecule
- genome editing
- circulating tumor
- cell free
- nucleic acid
- sensitive detection
- cell proliferation
- long non coding rna
- papillary thyroid
- mesenchymal stem cells
- climate change
- stem cells
- magnetic nanoparticles
- gene expression
- quantum dots
- genome wide
- computed tomography
- squamous cell carcinoma
- risk assessment
- high resolution
- long noncoding rna
- bone marrow
- endothelial cells
- squamous cell
- dna binding
- transcription factor
- childhood cancer